Title of article
The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc
Author/Authors
Paul L. Greer، نويسنده , , Rikinari Hanayama، نويسنده , , Brenda L. Bloodgood، نويسنده , , Alan R. Mardinly، نويسنده , , David M. Lipton، نويسنده , , Steven W. Flavell، نويسنده , , Tae-Kyung Kim، نويسنده , , Eric C. Griffith، نويسنده , , Zachary Waldon، نويسنده , , Rene Maehr، نويسنده , , Hidde L. Ploegh، نويسنده , , Shoaib Chowdhury، نويسنده , , Paul F. Worley، نويسنده , , Judith Steen، نويسنده , , Michael E. Greenberg، نويسنده ,
Issue Information
هفته نامه با شماره پیاپی سال 2010
Pages
13
From page
704
To page
716
Abstract
Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin ligase Ube3A, a gene whose mutation has also recently been associated with autism spectrum disorders (ASDs). The function of Ube3A during nervous system development and how Ube3A mutations give rise to cognitive impairment in individuals with Angleman Syndrome and ASDs are not clear. We report here that experience-driven neuronal activity induces Ube3A transcription and that Ube3A then regulates excitatory synapse development by controlling the degradation of Arc, a synaptic protein that promotes the internalization of the AMPA subtype of glutamate receptors. We find that disruption of Ube3A function in neurons leads to an increase in Arc expression and a concomitant decrease in the number of AMPA receptors at excitatory synapses. We propose that this deregulation of AMPA receptor expression at synapses may contribute to the cognitive dysfunction that occurs in Angelman Syndrome and possibly other ASDs.
Journal title
CELL
Serial Year
2010
Journal title
CELL
Record number
1020244
Link To Document